Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kirshenbaum

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Substance Use & Misuse|March 8, 2021
Variations in Protection Provisions Among State Medical Amnesty LawsVictoria A Knoche, Tatyana Kaplan, Jacqueline M Kirshenbaum, et al.
Journal of the American College of Cardiology|September 1, 1988
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapyJ M Kirshenbaum, R F Kloner, N McGowan, et al.
Circulation|October 1, 1985
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemiaJ M Kirshenbaum, R A Kloner, E M Antman, et al.
Clinical Pharmacology and Therapeutics|March 1, 1981
Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjectsW E Mitch, M W Johnson, J M Kirshenbaum, et al.
Clinical Cardiology|February 1, 1989
Left ventricular tamponade: echocardiographic and hemodynamic manifestationsR T Lee, S J Bhatia, J M Kirshenbaum, et al.
The New England Journal of Medicine|March 30, 2017
Under PressureErsilia M DeFilippis, Anand Vaidya, Subha Ramani, et al.
The New England Journal of Medicine|April 4, 2019
A Dangerous DetourDavid D Berg, James M Kirshenbaum, Elizabeth Gay, et al.
The American Journal of Medicine|March 23, 1987
Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135A R Brasier, J D Macklis, D Vaughan, et al.
Reproductive Biology and Endocrinology : RB&E|December 10, 2021
Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?M Kirshenbaum, O Gil, J Haas, et al.
Circulation|August 1, 1986
Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplastyP L Friedman, T L Shook, J M Kirshenbaum, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Substance Use & Misuse|March 8, 2021
Variations in Protection Provisions Among State Medical Amnesty LawsVictoria A Knoche, Tatyana Kaplan, Jacqueline M Kirshenbaum, et al.
Journal of the American College of Cardiology|September 1, 1988
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapyJ M Kirshenbaum, R F Kloner, N McGowan, et al.
Circulation|October 1, 1985
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemiaJ M Kirshenbaum, R A Kloner, E M Antman, et al.
Clinical Pharmacology and Therapeutics|March 1, 1981
Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjectsW E Mitch, M W Johnson, J M Kirshenbaum, et al.
Clinical Cardiology|February 1, 1989
Left ventricular tamponade: echocardiographic and hemodynamic manifestationsR T Lee, S J Bhatia, J M Kirshenbaum, et al.
The New England Journal of Medicine|March 30, 2017
Under PressureErsilia M DeFilippis, Anand Vaidya, Subha Ramani, et al.
The New England Journal of Medicine|April 4, 2019
A Dangerous DetourDavid D Berg, James M Kirshenbaum, Elizabeth Gay, et al.
The American Journal of Medicine|March 23, 1987
Myopericarditis as an initial presentation of meningococcemia. Unusual manifestation of infection with serotype W135A R Brasier, J D Macklis, D Vaughan, et al.
Reproductive Biology and Endocrinology : RB&E|December 10, 2021
Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?M Kirshenbaum, O Gil, J Haas, et al.
Circulation|August 1, 1986
Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplastyP L Friedman, T L Shook, J M Kirshenbaum, et al.
Pageof 5